Inventor · disambiguated record
Mark Pogson
Also filed as: POGSON MARK
5 granted patents·5 pending applications·1 citations·filing 2017–2025
65Inventor score
Top patents by PatentIndex Score
10 records- 0175US12264343B2TCRa homing endonuclease variantsREGENERON PHARMA·Filed 2023·Granted Apr 1, 2025·0 cites·19 claims
- 0274US11802281B2Mammalian cell line for protein production and library generationETH ZUERICH·Filed 2017·Granted Oct 31, 2023·1 cites·13 claims
- 0370US12252690B2Mammalian cell line for protein production and library generationETH ZUERICH·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 0469US2025312451A1Multipartite receptor and signaling complexesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0569US2025242024A1Multipartite receptor and signaling complexesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0668US2025243478A1Mammalian cell line for protein production and library generationETH ZUERICH·Filed 2025·Application pending·0 cites
- 0761US12421315B2CLL-1 targeted immunotherapiesREGENERON PHARMA·Filed 2020·Granted Sep 23, 2025·0 cites·20 claims
- 0860US11591582B2TCRα homing endonuclease variants2SEVENTY BIO INC·Filed 2017·Granted Feb 28, 2023·0 cites·15 claims
- 0950US2022315638A1Cd123 targeted immunotherapies2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 1041US2022218745A1Multivalent chimeric antigen receptor2SEVENTY BIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Pogson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →